E.E.S. Related Published Studies
Well-designed clinical trials related to E.E.S. (Erythromycin)
Pharmacokinetics of azithromycin in plasma and sinus mucosal tissue following administration of extended-release or immediate-release formulations in adult patients with chronic rhinosinusitis. [2009.07]
Erythromycin establishes early oral feeding in neonates operated for congenital intestinal atresias. [2009.04]
Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. [2009.04]
Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function. [2009.03]
Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study. [2009]
Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. [2008.12.01]
Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. [2008.10]
Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study. [2008.09]
Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis. [2008.06]
Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history. [2008.05.28]
Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin. [2008.04]
Effect of erythromycin and gentamicin on abomasal emptying rate in suckling calves. [2008.01]
Oral amoxicillin vs. oral erythromycin in the treatment of pyoderma in Bamako, Mali: an open randomized trial. [2007.10]
Oral erythromycin accelerates impaired gastrointestinal motility after endoscopic mucosal resection. [2007.09]
Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. [2007.09]
Oral erythromycin accelerates impaired gastrointestinal motility after endoscopic mucosal resection. [2007.09]
Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans. [2007.07]
Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma. [2007.06.01]
Effects of uptake and efflux transporter inhibition on erythromycin breath test results. [2007.06]
High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants. [2007.05]
Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: a preliminary report. [2007.03]
Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. [2007.02]
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. [2007.02]
Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis. [2007.02]
Erythromycin and feeding intolerance in premature infants: a randomized trial. [2007.01]
Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy. [2007.01]
Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. [2007]
Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease. [2006.09]
The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity. [2006.09]
Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine. [2006.08]
Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. [2006.06]
Erythromycin promotes gastric emptying during acute pain in volunteers. [2006.06]
Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants. [2006.05]
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. [2006.04]
Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. [2006.02]
Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis. [2006.02]
The effect of erythromycin on video capsule endoscopy intestinal-transit time. [2006.02]
A randomized controlled trial of adjunctive erythromycin in women with idiopathic preterm labor. [2006.01]
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. [2006.01]
[Efficacy and safety of extended-release clarithromycin (5-day short-course) vs telithromycin, in acute bacterial exacerbation of chronic bronchitis] [2005.10]
Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults. [2005.10]
Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. [2005.09.24]
Pharmacokinetics of clarithromycin extended-release (ER) tablets in patients with AIDS. [2005.09]
Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia. [2005.09]
Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism. [2005.08]
Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin. [2005.07]
The effect of erythromycin and fluvoxamine on the pharmacokinetics of intravenous lidocaine. [2005.05]
[Pharmacokinetics of erythromycin stinoprate capsule] [2005.04]
Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. [2005.04]
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways. [2005.03]
Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis. [2005.02]
Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis. [2005.02]
Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study. [2005.01]
Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. [2005.01]
Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. [2005.01]
Well-designed clinical trials possibly related to E.E.S. (Erythromycin)
Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. [2009.09.02]
Nasopharyngeal carriage of S. pneumoniae among young children in rural Nepal. [2009.09]
Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial. [2009.08]
Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children. [2009.08]
The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms--a prospective randomized double-blind trial. [2009.07]
Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment. [2009.07]
Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration. [2009.07]
A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. [2009.06.15]
Antibiotic prophylaxis before second-trimester genetic amniocentesis (APGA): a single-centre open randomised controlled trial. [2009.06]
Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem. [2009.06]
Azithromycin effect on helicobacter pylori eradication: double blind randomized clinical trial. [2009.05]
Randomized trial of high dose azithromycin compared to standard dosing for children with severe trachoma in Tanzania. [2009.05]
Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. [2009.04]
A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country. [2009.04]
Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure. [2009.04]
Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial. [2009.04]
Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. [2009.03.28]
The influence of types of decision support on physicians' decision making. [2009.03]
A PK/PD approach on the effects of clarithromycin against oral and nasal microbiota of healthy volunteers. [2009.02]
Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens. [2009.02]
Preferred strategies of men and women for managing chlamydial infection. [2009.02]
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. [2009.02]
Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children. [2009.01.21]
Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting. [2009.01]
A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. [2009.01]
Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial. [2008.12.01]
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. [2008.12]
Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection. [2008.12]
Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options. [2008.12]
Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study. [2008.12]
Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial. [2008.12]
Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea. [2008.12]
Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities. [2008.12]
Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication. [2008.12]
Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis. [2008.11]
Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection. [2008.11]
Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers. [2008.11]
Clinical and microbiologic effects of subgingivally delivered 0.5% azithromycin in the treatment of chronic periodontitis. [2008.11]
Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers. [2008.11]
Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). [2008.10.08]
[Effect of Helicobacter pylori eradication on patients with functional dyspepsia] [2008.09]
Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. [2008.09]
Distribution of systemic clarithromycin to gingiva. [2008.09]
Antistreptococcal treatment of guttate psoriasis: a controlled study. [2008.09]
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. [2008.08.02]
Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study. [2008.08]
|
